Lilly Ventures has its roots in the scientific tradition of Eli Lilly and Company. Our investment philosophy drives us to seek great companies with compelling life science innovations. We partner actively with the management teams of our portfolio companies to realize the potential of their technologies. Accordingly, we provide both financial and intellectual resources to accelerate the management teams’ path to success. Lilly Ventures currently has $200 million under management with a focus on the North American and European regions.
Biotechnology: targeting investments in biotechnology companies that leverage proprietary drug discovery or development technologies to build a multi-product pipeline.
Medical Technology: targeting investments in companies focusing on the convergence of devices with pharmaceuticals or diagnostics.
Through our relationship with Eli Lilly and Company, Lilly Ventures provides our portfolio companies with access to the collective knowledge and contact base generated by Lilly’s world-class scientists, experienced clinical investigators and respected sales and marketing professionals
Our relationship with Eli Lilly and Company greatly enhances our ability to evaluate new technologies and therapies from a customer or prospective partner perspective.
Our collaborations with industry experts, the venture capital industry and investment banks give us a global network of contacts to assist portfolio companies with various aspects of growing their business.